Empesertib (BAY1161909) is an experimental drug which acts as a selective inhibitor of the enzyme monopolar spindle 1 kinase (MPS1). It is in clinical trials for the treatment of breast cancer.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.